NCT02296424 - ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

November 17, 2014

Primary Completion Date

October 14, 2016

Study Completion Date

September 25, 2017

Conditions

Systemic Juvenile Idiopathic Arthritis (SJIA)

Interventions

DRUG

ACZ885 150 mg (Canakinumab)

Active canakinumab in individual 2 mL glass vials, each containing 150 mg canakinumab liquid in vial.

Trial Locations (50)

1020

Novartis Investigative Site, Laken

1023

Novartis Investigative Site, Budapest

1094

Novartis Investigative Site, Budapest

1200

Novartis Investigative Site, Brussels

3000

Novartis Investigative Site, Leuven

13125

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

16147

Novartis Investigative Site, Genova

17176

Novartis Investigative Site, Stockholm

20100

Novartis Investigative Site, Milan

20246

Novartis Investigative Site, Hamburg

22081

Novartis Investigative Site, Hamburg

28009

Novartis Investigative Site, Madrid

28034

Novartis Investigative Site, Madrid

28046

Novartis Investigative Site, Madrid

29011

Novartis Investigative Site, Málaga

34098

Novartis Investigative Site, Istanbul

34722

Novartis Investigative Site, Istanbul

35340

Novartis Investigative Site, Izmir

35392

Novartis Investigative Site, Giessen

40138

Novartis Investigative Site, Bologna

43205

Novartis Investigative Site, Columbus

46026

Novartis Investigative Site, Valencia

49202

Novartis Investigative Site, Petah Tikva

53757

Novartis Investigative Site, Sankt Augustin

69120

Novartis Investigative Site, Heidelberg

69677

Novartis Investigative Site, Bron

72076

Novartis Investigative Site, Tübingen

75015

Novartis Investigative Site, Paris

79106

Novartis Investigative Site, Freiburg im Breisgau

80131

Novartis Investigative Site, Napoli

90027

Novartis Investigative Site, Los Angeles

91031

Novartis Investigative Site, Jerusalem

94275

Novartis Investigative Site, Le Kremlin-Bicêtre

119991

Novartis Investigative Site, Moscow

194100

Novartis Investigative Site, Saint Petersburg

3525408

Novartis Investigative Site, Haifa

4428164

Novartis Investigative Site, Kfar Saba

5265601

Novartis Investigative Site, Ramat Gan

A-1090

Novartis Investigative Site, Vienna

80250-030

Novartis Investigative Site, Curitiba

21941-912

Novartis Investigative Site, Rio de Janeiro

05403-000

Novartis Investigative Site, São Paulo

V6H 3V4

Novartis Investigative Site, Vancouver

M5G 1X8

Novartis Investigative Site, Toronto

00165

Novartis Investigative Site, Roma

3584 EA

Novartis Investigative Site, Utrecht

02637

Novartis Investigative Site, Warsaw

08950

Novartis Investigative Site, Esplugues de Llobregat

06100

Novartis Investigative Site, Ankara